Director, CEO · Estrella Immunopharma, Inc. · Common Stock, par value $0.0001 per share
Side
M
Value
$82K
Shares
100.0K
Price
$0.82
Executed
Aug 25, 2026
Disclosed
Aug 26, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Aug 25 executedAug 26, 2026 disclosed
ESLA · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+12 / 25
$82K reported value · 33.6% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Liu Cheng filed this Form 4 reporting a option exercise of ESLA on Aug 25, 2026. It became public on Aug 26, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, CEO
Liu Chengcik:0001996255
Issuer
Estrella Immunopharma, Inc.cik:0001844417
Revision history · 0
No field has changed since this record was first ingested.
